trending Market Intelligence /marketintelligence/en/news-insights/trending/nYtXGhQVhRykOFlPqlZNWQ2 content esgSubNav
In This List

Intellia Therapeutics director resigns

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Intellia Therapeutics director resigns

Moncef Slaoui resigned as a board member of Intellia Therapeutics Inc. due to a conflict of interest, effective Aug. 7.

Slaoui was added to the board in July. His decision to resign did not result from any disagreement with the company on any matter relating to its operations, policies or practices.